DESTINY PHARMA PLC LS-01 Logo
GB00BDHSP575
A2DW69

DESTINY PHARMA PLC LS-01

Loading quotes...

Forecast

There is no analyst data available for this company.

Historical dividends Dividends

All dividend metrics All metrics
In 2022, DESTINY PHARMA PLC LS-01 has already paid €0.0638 in dividends. The last payout was in January 2022.

Financials

In the last year, DESTINY PHARMA PLC LS-01 had revenue of €957.58K and net profit of -€6.51M
(EUR) 2023
YoY
Revenue 957.58K 449.55%
Gross profit 950.45K 492.75%
Net profit -6.51M 11.19%
EBITDA -7.56M 13.68%

Fundamentals

Metric Value
Market capitalization
€3.34M
Number of shares
95.77M
52-week high/low
€0.98 - €0.00
Dividends No
Beta
0.22
P/E ratio
-0.48
PEG ratio
0.00
P/B ratio
0.30
P/S ratio
3.46

Company profile

Name
DESTINY PHARMA PLC LS-01
CEO
Christopher John Tovey BSc
Employees 15
🍪

Parqet  uses cookies. Learn more